Enforcement record

認定 disclosure naming 株式会社大賀薬局

株式会社大賀薬局 (産業競争力強化法)

This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.

産業競争力強化法Ministry of Health, Labour and WelfareGovernment disclosure30 September 2025

Action type

認定

Law

産業競争力強化法

Authority

Ministry of Health, Labour and Welfare

Action date

30 September 2025

Current page: Enforcement record

This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.

Source verification

Public-source and preservation status

Publishing authority: Ministry of Health, Labour and Welfare
Official source URL: Recorded by RegBase
Entity match: Not confirmed; shown under the published name
Kiroku preservation: Completed archive verified; Captured: Jul 12, 2026, 03:41 PM JST

“Confirmed” means that RegBase matched this record to the cited public disclosure or entity under the stated checks. It does not verify the truth of the disclosure or guarantee the entity’s current status, creditworthiness, or any legal conclusion.

Open the official source links in the section below to review the original disclosure.

Action summary

Company: 株式会社大賀薬局Japanese only
Original: 株式会社大賀薬局
Governing law: 産業競争力強化法
産業競争力強化法
Action type: 認定
認定
Action date: 30 September 2025
Issuing authority: Ministry of Health, Labour and Welfare
厚生労働省
Industry context: 医薬品・薬局

Violation

Machine-translated summary — verify against original

Regarding the 'Business Reorganization Plan' submitted by Oga Holdings Co., Ltd. and Oga Pharmacy Co., Ltd., a review was conducted based on Article 23, Paragraph 1 of the Act on Strengthening Industrial Competitiveness. It was determined that the planned business reorganization qualifies as a reorganization under Article 2, Paragraph 17 of the same Act and meets the certification requirements stipulated by the Act. Therefore, the plan was certified.

Show original Japanese text

株式会社オーガホールディングス及び株式会社大賀薬局から提出された「事業再編計画」について、産業競争力強化法第23条第１項の規定に基づき審査した結果、同法第２条第17項に規定する事業再編を実施するものとして、同法で定める認定要件を満たすと認められるため、「事業再編計画」の認定を行いました。

Compliance context

Context needed

This is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.

Japanese regulatory disclosure under 産業競争力強化法.

Review the original Japanese source and determine relevance to your counterparty-risk workflow.

This context is an operational aid for review workflows, not a credit opinion or legal conclusion.

Open original sources and verification detailsOfficial URL, direct PDF, and Kiroku archive

Original Ministry of Health, Labour and Welfare source (Japanese)Open preserved source and evidence pack

Extracted at: 2026-04-24T23:39:02.554+00:00
Evidence checked: 2026-04-24T23:39:02.554+00:00
Archive captured: 2026-07-12T06:41:43.801866+00:00

Show audit JSON

{
  "record": {
    "id": "2a195c53-cea7-4c33-b82c-cfcc5efed10c",
    "url": "https://regbase.jp/en/enforcement/other-da-he-yao-ju-20250930",
    "company_name_original": "株式会社大賀薬局",
    "company_name_registry": null,
    "corporate_number": null,
    "law": {
      "ja": "産業競争力強化法",
      "en": "産業競争力強化法"
    },
    "action_type": {
      "ja": "認定",
      "en": "認定"
    },
    "authority": {
      "ja": "厚生労働省",
      "en": "Ministry of Health, Labour and Welfare"
    }
  },
  "entity_match": {
    "status": "unresolved",
    "confidence": 85,
    "method": "nta_strict_name_nationally_unique",
    "method_label": "nta_strict_name_nationally_unique",
    "notes": "NTA full-download lookup found a nationally unique exact registered-name candidate (株式会社大賀薬局). No Corporate Number was present in the disclosure, so this remains a likely match."
  },
  "review": {
    "status": "unreviewed",
    "label": "Machine extracted"
  },
  "compliance_context": {
    "severity": "Context needed",
    "actionMeaning": "This is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.",
    "practicalNote": "Review the original Japanese source and determine relevance to your counterparty-risk workflow.",
    "lawContext": "Japanese regulatory disclosure under 産業競争力強化法."
  },
  "evidence": {
    "recordUrl": "https://regbase.jp/en/enforcement/other-da-he-yao-ju-20250930",
    "officialSourceUrl": "https://www.mhlw.go.jp/stf/newpage_63961.html",
    "officialDocumentUrl": null,
    "archiveUrl": "https://kiroku.today/a/5f03082a08hfc39v",
    "archivedSourceUrl": "https://www.mhlw.go.jp/stf/newpage_63961.html",
    "archiveCapturedAt": "2026-07-12T06:41:43.801866+00:00",
    "extractedAt": "2026-04-24T23:39:02.554+00:00",
    "translatedAt": "2026-05-01T06:53:02.6+00:00",
    "evidenceCheckedAt": "2026-04-24T23:39:02.554+00:00",
    "generatedAt": "2026-09-18T20:02:08.987Z"
  },
  "limitations": [
    "RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
    "English summaries are provided for reference. The original Japanese source is authoritative.",
    "Possible or unresolved entity matches should be manually verified before use in a decision."
  ]
}

The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.

Language

日本語版を見る (Japanese)

About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.